Subject(s)
Colonic Polyps/diagnosis , Contrast Media , Enema/methods , Magnetic Resonance Imaging/methods , Air , Animals , Gadolinium DTPA , Sensitivity and Specificity , Swine , WaterABSTRACT
Mesoaortic compression of left renal vein produces left renal vein hypertension resulting in left flank pain, hematuria and pelvic-ureteral varices. This is called the nutcracker syndrome. The nutcracker syndrome has been treated in various ways. We recently experienced two cases of patients with nutcracker syndrome. We treated the patients with transposition of their left renal vein.
Subject(s)
Peripheral Vascular Diseases/surgery , Renal Veins , Vascular Surgical Procedures/methods , Adult , Constriction, Pathologic , Diagnosis, Differential , Female , Follow-Up Studies , Hematuria/diagnosis , Humans , Male , Peripheral Vascular Diseases/diagnostic imaging , Phlebography , Renal Veins/diagnostic imaging , Renal Veins/surgery , Syndrome , Tomography, X-Ray ComputedABSTRACT
Iodide mumps, swelling of salivary glands after contrast medium injection, is a rare adverse reaction. We present a case in a 73-year-old man with advanced gastric cancer. About 10 min after a CT scan performed with intravenous injection of 140 ml of the low osmolality contrast agent Ioxaglate (Hexabrix 320, Guerbet, France), he complained of progressive swelling of the submandibular area. Ultrasound showed diffuse swelling and internal low echoic thick septa in the submandibular glands bilaterally. Approximately 1 h afterwards, the swelling of his submandibular glands started to regress and returned to normal within a day.
Subject(s)
Contrast Media/adverse effects , Ioxaglic Acid/adverse effects , Submandibular Gland Diseases/diagnostic imaging , Aged , Edema/chemically induced , Edema/diagnostic imaging , Humans , Male , Stomach Neoplasms/diagnostic imaging , Submandibular Gland Diseases/chemically induced , Tomography, X-Ray Computed , UltrasonographyABSTRACT
OBJECTIVE: Superior mesenteric vein thrombosis (SMVT) is generally difficult to diagnose and can be fatal. Mesenteric and portal vein thrombosis is rare and can be presented as more serious conditions than that of SMVT. We report patients with combined SMVT and portal vein thrombosis (PVT) who were treated successfully with early initiation of anticoagulation. METHODS: The medical records of six patients (five male, one female) who presented with combined SMVT and PVT in our institute between January 1994 and September 2003 were reviewed retrospectively. All of the patients were treated with early initiation of anticoagulation using unfractionated heparin or low molecular weight heparin. RESULTS: The mean hospital stay was 31 days and the mean follow-up period was 32 months. Three patients had an antithrombin III deficiency. The most common symptom was diffuse abdominal pain and signs included abdominal distension and tenderness. During the follow-up period, there were two patients who developed stricture of the small bowel necessitating resection and anastomosis of the small bowel. There was no case of peritonitis due to bowel necrosis or mortality. CONCLUSION: The early initiation of anticoagulation in patients of SMVT combined with PVT could minimise the serious complication such as peritonitis due to bowel necrosis required immediate exploratory laparotomy.
Subject(s)
Anticoagulants/therapeutic use , Heparin/therapeutic use , Mesenteric Veins , Portal Vein , Venous Thrombosis/drug therapy , Adult , Aged , Antithrombin III Deficiency/complications , Esophageal and Gastric Varices , Female , Humans , Intestinal Obstruction/complications , Intestinal Obstruction/surgery , Male , Middle Aged , Pleural Effusion/complications , Venous Thrombosis/diagnosisSubject(s)
Cattle/growth & development , Cattle/genetics , Growth Hormone/genetics , Polymorphism, Genetic , Animals , Base Sequence , Body Weights and Measures , DNA Primers , Korea , Linear Models , Molecular Sequence Data , Polymorphism, Restriction Fragment Length , Regulatory Sequences, Nucleic Acid/genetics , Sequence Analysis, DNA , Species SpecificityABSTRACT
PURPOSE: To assess the application of stent-grafts in the management of aortic and arterial aneurysms in patients with Behçet disease. MATERIALS AND METHODS: Nine aneurysms in seven patients were managed with various types of stent-grafts. Diagnoses were based on clinical findings. The aortic aneurysms (n = 3) were thoracic (n = 1), suprarenal (n = 1), or infrarenal (n = 1). The arterial aneurysms (n = 6) were in the right and left subclavian (n = 2), right common carotid (n = 2), right brachiocephalic (n = 1), or left common iliac arteries (n = 1). A tandem connection of Gianturco stent covered with polytetrafluorethylene was placed in three aneurysms, and a balloon-expandable stent was placed in six. RESULTS: The stent-graft was successfully placed in all patients. Immediate follow-up angiography revealed complete exclusion of the aneurysm in all cases. Follow-up computed tomography performed 3 days to 2 weeks later revealed complete exclusion and thrombosis of the aneurysm and patency of the stent-graft in six patients. In one patient, total occlusion of the artery with a stent occurred due to flow disturbance caused by double lesions. During follow-up (range, 6-59 months; mean, 28 months), the aneurysm resolved and completely regressed in four patients. A recurrent aneurysm at the distal margin of previously inserted stent-graft was successfully managed with an additional stent-graft. CONCLUSION: The findings in this initial experience suggest that stent-graft insertion may be a safe and effective alternative to surgical treatment of aortic and arterial aneurysms in patients with Behçet disease.
